Prelude Therapeutics Incorporated
Records under this name other than the patents Prelude Therapeutics Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
Showing 1 to 5 of 5 · Back to Prelude Therapeutics Incorporated
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,220,524 | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Lapsed on the fee record Ended Jan 11, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 11, 2026 | USPTO record |
| US 11,214,574 | Selective Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) Lapsed on the fee record Ended Jan 4, 2026 · Medium confidence | Lapsed on the fee record | Ended Jan 4, 2026 | Medium confidence |
| US 11,208,416 | Selective inhibitors of protein arginine methytransterase 5 (PRMT5) Lapsed on the fee record Ended Dec 28, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 28, 2025 | USPTO record |
| US 11,130,769 | Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein Lapsed on the fee record Ended Sep 28, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2025 | USPTO record |
| US 11,078,205 | Selective inhibitors of protein arginine methlytransferase 5 (PRMT5) Lapsed on the fee record Ended Aug 3, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 3, 2025 | USPTO record |